Jonah, de 8 años, se despertó una mañana de mayo con la cara hinchada y dolor de muelas. Se negó a tomar el medicamento para el dolor que su mamá, Geneva Reynolds, trató de darle. No dormía ni comía y lloraba sin parar. En pocos días, Reynolds estaba tan desesperada que ella y su esposo…
By KIM BELLARD A recent report from Moody’s Analytics, by chief economist Mark Zandi, had an eye-opening fact: the top 10% of earners in the U.S. – those who make $250,000 or more – now account for just shy (49.7%) of half of consumer spending. If that strikes you as unusual, you’re right. It is…
KFF Health News Midwest correspondent Cara Anthony sat down with WORLD executive producer Chris Hastings to discuss the origins of the “Silence in Sikeston” project, which explores the impact of a 1942 lynching and a 2020 police shooting on a rural Missouri community. The collaboration with Retro Report includes a documentary film, educational videos, digital…
If leading hospitals are using these AI tools, and the companies mention HIPAA compliance on their websites, are the consumer AI health tools also regulated by HIPAA? Do consumers share a similar relationship with these companies as healthcare organizations do? The post Privacy Expectations in Consumer AI Tools: How Patient Use of ChatGPT Health and…
A new survey finds that employers are moving away from the Big Three PBMs while prioritizing healthcare affordability and transparency. The post Report: Employers’ Use of Big Three PBMs Falls in 2026 appeared first on MedCity News.
Executives of the California Medicaid insurer discuss the impact of new CalAIM benefits on the deployment of community health workers
By LEONARD D’ AVOLIO The murder of UnitedHealthcare CEO Brian Thompson has drawn attention to Americans’ frustration with the for profit healthcare insurance industry. Change is possible but less likely if people don’t understand how we got here, the real issues, and how they might be fixed. Health insurance wasn’t always run by big for…
When doctors told her they had to remove her tongue and voice box to save her life from the cancer that had invaded her mouth, Sonya Sotinsky sat down with a microphone to record herself saying the things she would never again be able to say. “Happy birthday” and “I’m proud of you” topped the…
The Medicare Part D prescription drug benefit is provided by private plans, either Medicare Advantage plans that offer drug coverage (MA-PDs) or, for those in traditional Medicare, stand-alone prescription drug plans (PDPs). New data from CMS shows that 56 million people are enrolled in Part D plans as of February 2026, with more in MA-PDs…
KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications. The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity…